GEM Aromatics is set to commission its new specialty molecules manufacturing facility in November 2025, following the receipt of all regulatory approvals and the completion of successful product trial runs. The company has invested approximately ₹250 crore in the project through a combination of internal accruals and debt.
The new plant will add 10,829 MTPA of additional capacity across four segments. This includes a 500 MTPA cooling agents unit — poised to be the largest in India — along with a phenol derivatives unit leveraging next-generation vapor phase technology. The facility is designed to produce a wide range of high-value specialty molecules such as Cooling Agents, MEHQ, BHA, Safranal, Damascone, Eugenol Derivatives, and Guaiacol.
GEM Aromatics has also qualified for a 15% corporate tax rate in perpetuity under government incentive schemes, significantly enhancing long-term financial viability. The expansion incorporates both backward and forward integration to improve process control, elevate product quality, and strengthen customisation capabilities.
The company already operates three manufacturing units located in Uttar Pradesh, Gujarat, and Daman & Diu, with a combined installed capacity of 5,346 MTPA. A major expansion at its Dahej plant is currently in progress, further augmenting GEM Aromatics’ capacity in the fast-growing specialty chemicals sector.